Marisa Taylor is a senior correspondent on the KHN enterprise team. She investigates end-of-life care and acute medical care, among other health care topics.
Marisa Taylor
From this contributor
Immigrant children detained in U.S. may struggle to get health care
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
3 July 2018 | 5 min read
Thousands of children younger than 13 detained under U.S. border policy
The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown.
Thousands of children younger than 13 detained under U.S. border policy
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
22 June 2018 | 6 min read
Federal limits on medical marijuana research hinder treatments
By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.
Federal limits on medical marijuana research hinder treatments
By
Melissa Bailey, Marisa Taylor, Kaiser Health News
16 April 2018 | 9 min read
Trading controversy dogs health secretary nominee Tom Price
U.S. Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading, despite the fact that a House committee he was on was under investigation.
Trading controversy dogs health secretary nominee Tom Price
By
Marisa Taylor, Christina Jewett, Kaiser Health News
9 February 2017 | 7 min read
Explore more from The Transmitter
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
By
Katie Moisse
15 December 2025 | 7 min read
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
By
Alex Kwan
15 December 2025 | 6 min read
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
By
Claudia López Lloreda
12 December 2025 | 5 min read